Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07857980 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of School-Based Ignatian Examen Meditation on Well-Being, Gratitude, Hope, and Spirituality in Hong Kong Catholic Primary School Students

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to investigate the effects of Ignatian Examen Meditation on students' psychological well-being, gratitude, hope, and spirituality. Specifically, it examines whether participation in Examen Meditation improves emotional well-being by reducing stress, anxiety, and depression, enhancing students' sense of gratitude and hope, and strengthening spiritual development. The study also explores the lived experiences of students and teachers who participate in the programme. Regarding significance, this study addresses the lack of empirical studies examining Examen Meditation in Asian educational settings. The findings will provide evidence regarding the effectiveness of a Catholic contemplative practice in supporting students' mental health and spiritual formation. It may contribute to the development of school-based well-being programmes in Catholic schools by demonstrating the potential benefits of Examen Meditation for psychological well-being, the sense of gratitude and hope and spiritual growth.
Trial Details
NCT Number NCT07857980
Lead Sponsor Chinese University of Hong Kong
Conditions Psychological Well-being, Gratitude, Hope, Spirituality, Stress, Anxiety, Depression
Enrollment 360 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov